HHS
College of American Pathologists Calls on HHS to End FDA Oversight of LDTs
CAP suggested in a letter to HHS that FDA regulation of LDTs conflicts with President Donald Trump's Jan. 31 executive order instructing agencies to reduce regulations.
CMS Potentially Overpaid for OTC COVID-19 Tests by up to $453.8M, HHS OIG Report Finds
CMS officials said they have implemented national controls and sought repayment from dozens of healthcare providers and suppliers.
Following pushback from industry stakeholders, the Trump administration appears to have reversed a number of the planned CDRH layoffs.
HHS Report Finds Medicare Lab Spending Dropped 5 Percent in 2023 on Lower COVID-19 Volumes
The report also indicates that while PAMA has cut spending on routine tests, overall lab spending has risen as genetic testing continues to grow.
ARPA-H Awards $110M to Commercial, Academic Teams Tackling Women's Health
The awardees included several diagnostics firms, among them Aspira Women's Health, which received $10 million for development of its EndoMDx test.